CYTOSAR-U INJECTION 20mg/ml is a sterile solution of Cytarabine, used primarily in the treatment of certain types of cancers, including leukemia and lymphoma. This medication is administered via injection and is formulated to provide effective chemotherapy treatment.
The dosage of CYTOSAR-U INJECTION should be determined by a healthcare professional based on the patient's condition and response to treatment. It is typically administered intravenously or intrathecally.
Common side effects may include:
Consult your healthcare provider for a complete list of possible side effects and to discuss any concerns.
Inform your doctor about any allergies, current medications, and medical history, especially if you have liver or kidney issues.
CYTOSAR-U can cause harm to an unborn baby. It is important to discuss potential risks with your healthcare provider if you are pregnant or planning to become pregnant.
CYTOSAR-U is administered by a healthcare professional either through an intravenous (IV) line or directly into the cerebrospinal fluid.